Bicuspid aortic valve affects up to one in 50 people, but many don't know they have this congenital heart defect until ...

Doctors say up to one in 50 people are born with a bicuspid aortic valve which needs regular checks - but many are not ...

Bicuspid aortic valve affects up to one in 50 people, but many don't know they have the heart defect until symptoms appear in ...

According to National Family Health Survey, over 35–40% of urban men aged 25–54 are already hypertensive, with prehypertension peaking at around 36% in the 30–39 group ...

Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and ...

Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in ...

Novo Nordisk advanced coramitug into the Phase III CLEOPATTRA trial, evaluating 1,280 patients with amyloid transthyretin cardiomyopathy or ATTR-CM. This decision was informed by results from their ...

Standing on the second hole, a long par five, Thomas Todd steadied himself and swung. He hit a decent shot off the tee ...

Many people at risk for heart failure remain stable over time, some worsen, but others improve as well. Blood tests and heart ...

BACKGROUND: Forecasts for the future prevalence of cardiovascular disease and stroke are crucial to guide efforts to improve health outcomes across the life course for women. METHODS: Using historical ...

Early detection and prompt treatment of acute pulmonary embolism (PE), a sudden and potentially life-threatening blood clot that blocks arteries in the lungs, is critical. Comprehensive ...

A woman in her 40s presented with progressive cognitive decline, expressive language difficulty and episodic confusion. Her initial symptoms were misattributed to psychiatric illness, and later to ...